<DOC>
	<DOCNO>NCT00766402</DOCNO>
	<brief_summary>The purpose study investigate clinical benefit tramadol/acetaminophen versus non-steroidal anti-inflammatory drug ( NSAID ) ( diclofenac 50 milligram [ mg ] ) treatment pain participant ankylose spondylitis ( inflammation spine cause pain stiffness ) receive stable treatment disease modify anti-rheumatic drug ( DMARDs ) .</brief_summary>
	<brief_title>An Efficacy Safety Study Tramadol/Acetaminophen Versus Diclofenac Treatment Pain Participants With Ankylosing Spondylitis Receiving Stable Treatment Disease Modifying Anti-rheumatic Drugs ( DMARDs )</brief_title>
	<detailed_description>This single center , open label ( people know identity intervention ) , randomize ( study drug assign chance ) , parallel group ( medical research study compare response two group participant receive different intervention ( treatment ) trial compare effectiveness ( pain relief ) safety tramadol 37.5 mg acetaminophen 325 mg diclofenac participant ankylose spondylitis receive stable treatment disease modify anti-rheumatic drug ( DMARDs ) . Participants meet eligibility criterion randomize one two treatment group ( tramadol/acetaminophen Diclofenac ) . One group treat tramadol 37.5 mg/acetaminophen 325 mg combination tablet another group treat diclofenac 50 mg tablet . Participants randomize study instruct take one tablet Ultracet diclofenac 50 mg orally , twice day 8 week . Evaluations perform outline : Screening , Baseline , Weeks 2 , 4 , 8 . The primary efficacy parameter compare mean change Baseline visual analogue scale ( VAS ) pain score two treatment group ( tramadol/acetaminophen versus diclofenac ) . Participants ' safety monitor throughout study .</detailed_description>
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Tramadol</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<mesh_term>Antirheumatic Agents</mesh_term>
	<criteria>Diagnosis ankylose spondylitis ( AS ) , define Modified New York Criteria ankylose spondylitis : ) Lowback pain least 3 month duration improve exercise relieve rest b ) Limitation lumbar spine sagittal frontal plane c ) Chest expansion decrease relative normal value age sex ) Bilateral sacroiliitis , grade 24 Unilateral sacroiliitis , grade 34 ( Stoke ) Participants suffer pain , visual analogue scale ( VAS ) pain score great equal ( &gt; = ) 40 millimeter ( mm ) Participants receive disease modify antirheumatic drug ( DMARDs ) , reach stable dosage within 4 week prior randomization visit Serum creatinine less equal ( &lt; = ) 1.2 milligram per deciliter ( mg/dL ) Aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) &lt; = 3 time laboratory 's upper limit normal Had inadequate response tramadol hydrochloride ( HCl ) therapy , discontinue tramadol HCl therapy due adverse event Have take tramadol HCl within 4 week prior entry study Have take medication pain relief within 4 week prior entry study , except rescue medication Evidence significant uncontrolled concomitant diseases cardiovascular disease , nervous system , pulmonary , renal , hepatic , endocrine gastrointestinal disorder Women pregnancy breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Spondylitis , ankylose</keyword>
	<keyword>Pain</keyword>
	<keyword>Ultracet</keyword>
	<keyword>Diclofenac</keyword>
	<keyword>Voltaren</keyword>
	<keyword>Tramadol/acetaminophen</keyword>
</DOC>